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CHARACTERIZATION OF PHYTOCYSTATIN-LIKE CYSTEINE PROTEASE 






by Ryan M. J. Faucher 




 Trichomoniasis is a common STD caused by the parasitic protozoan Trichomonas 
vaginalis.  The parasite isf estimated to have infected roughly 3.7 million Americans.  
Complications from trichomoniasis can lead to cervical cancer in women and prostate 
cancer in men.  One of the mechanisms of the parasite employs is using cysteine 
proteases to break down the cellular matrix of its host.  However, three endogenous 
phytocystatin-like protease inhibitors have been found within the parasite’s genome.  By 
recombinantly expressing these cystatins we have been able to test their ability to inhibit 
cysteine proteases such as papain and those found in T. vaginalis to find their 
effectiveness.  By characterizing these inhibitors, it appears that they are effective at 
reducing the ability of T. vaginalis cysteine proteases and thus could be useful against the 
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Chapter 1: Introduction 
 Trichomonas vaginalis (T.vaginalis) is a parasitic protozoan and is one of the 
most common sexually transmitted infections in industrialized nations, infecting 
approximately 160 million people worldwide (Harp, 2011).  As can be seen in Figure 1 
the parasite has multiple flagella that give it the ability to move freely in the host.  
Despite the flagella the parasite is able to adhere to the vaginal epithelial cells (Arroyo, 
1992).  The parasite is able to accomplish this by utilizing microtubules, microfilaments, 
and adhesin enzymes that are capable of binding to receptor molecules on vaginal 
epithelial cells.  The parasite also lacks mitochondria, so it is anaerobic and does not 










The protozoan is relatively small, only slightly larger than a white blood cell or 
approximately 9x7 micrometers in size.  Due to its small size and the fact that it does not 
form cysts in the host’s epithelial cell layer, it can be difficult to identify infection.  An 
overnight culture would usually have to be grown in order to see if a patient has been 
infected.  Some of the complications see in pregnant women infected by T. vaginalis 
include lower birth weight, early delivery, and increased mortality rate, as well as making 
the host (pregnant or non-pregnant) more predisposed to HIV, AIDS, and cervical cancer 
(Schwebke, 2004).  Treatment to eliminate the parasite will usually consist of doses of 
metronidazole and tinidazole, which are anti-parasitic drugs.   
 T. vaginalis is capable of thriving in both men and women (especially if the pH 
level in the host is raised from a healthy acidic level to a more unhealthy neutral level, 
which is more conducive for T. vaginalis growth); however, women show symptoms of 
the infection through the disease trichomoniasis, in which the host will have 
inflammation in the area of infection.  Men, on the other hand, may not show any signs of 
infection, making detection of T. vaginalis infection is much more difficult.  The 
infection is, however, capable of increasing the risk of prostate cancer in men despite 
there being little to no signs of infection because of no symptoms (Stark, 2009).   
 The symptoms that occur in female hosts are caused by the parasite releasing 
cysteine proteases and cytotoxic secretions into the mucosal layer of the host, which 
results in apoptosis of the epithelial cell layer (Sommer, 2005). These proteases have 
been known to increase the likelihood of the host to acquire other STDs such as HIV by 
destroying the host’s extracellular matrix, the host’s immunoglobulins, and even host 





 A Cysteine protease (CP) is an enzyme that degrades other proteins.  This would 
mean that during an infection of T. vaginalis, the CPs that are released from the parasite 
will bind to and degrade proteins on the surface of host epithelial cells.  The mechanism 
of how this works can be seen in Figure 2.  As can be seen in the figure, a peptide bond 
will undergo a nucleophilic attack by the amino acid cysteine.  This will in turn cause the 
peptide bond to be cleaved and then be stabilized with a water molecule.  This 
mechanism is what allows the cysteine proteases to be able to degrade other proteins and 
render them useless. 
 Cysteine proteases are used by many organisms as a form of control of the 
contents of the cytoplasm.  CPs will degrade proteins in order to maintain proper cellular 
function by not allowing too many proteins to become active in the cell.  CPs in plants 
can be also used for programmed cell death, senescence (arrest of cell cycle), as well as 
protein storage, so they can be used for not just catabolic reactions but anabolic as well 








Figure 2. Cysteine Protease Chemical Mechanism. This figure shows the mechanism by 




Legumains are a specific type of intercellular cysteine protease with lysosomal 
functions.  They can be found in plants as well as in many other organisms.  In fact, 
legumains have an important function in humans by which they are able to break down 
peptides from outside the cell for presentation on MHC class II receptors, only found in 
immune cells such as macrophages and helper T cells, for immune system response 
(Chen, 1997).  T. vaginalis does not necessarily use CPs in the same manner as they have 
no need for such features as senescence or cell death.   
In addition to using CPs for invasion and consumption of host cells, T. vaginalis 
can utilize them as a defense mechanism.  During a T. vaginalis infection the host will try 
to defend itself by using an immunological response.  However, T. vaginalis will deploy 





able to attack the T. vaginalis parasite.  Not only do these CPs attack the immune system, 
they also attack the vaginal epithelial cell layer, thus inhibiting the host from being able 
to protect itself from other foreign contaminants, leaving the host more susceptible to 
other harmful parasites such as pathogens that cause diseases (such as HIV and AIDS).   
 With regards to how essential CPs are for normal cellular processes, there is no 
doubt that they are similar amongst organisms.  In fact there has been strong homology 
found between CPs from T. vaginalis and human cysteine protease cathepsin L (Sajid, 
2009).  This shows that these proteins are highly conserved and raises questions about 
how these proteins function. If the same inhibitors that work against one organism’s CPs 
can they inhibit another organism’s CPs?   
 It would be unwise for too many active proteases to be floating around inside the 
cells of an organism due to their destructive nature.  This is why organisms have also 
developed inhibitors for this protein.  In fact some organisms have evolved cysteine 
protease inhibitors (CPIs) specific for foreign CPs that come from parasitic organisms 
attacking the host (Stenman, 1997).  These help to regulate active protease levels not only 
within the cells but also within the extracellular matrix surrounding the cells. 
 Cysteine protease inhibitors are produced by cells to regulate the amount of 
cysteine proteases in the cytoplasm.  These inhibitors are generally small, roughly a 
hundred amino acids in length (Figure 3 shows a three-dimensional crystal structure of a 
cystatin cysteine protease inhibitor), and bind to the active site of the protease to limit its 
ability to bind to target proteins.  Their sole objective is to inhibit protease function so 
that the proteases do not degrade more proteins than they need to.  These inhibitors play a 













Some inhibitors are produced not for the organism's own proteases but rather for 
the CPs produced by foreign invaders of the host.  One such example would be Cystatin, 
a cysteine protease inhibitor that can be found in human fluids as well as secretions 
(Stenman 1997).  This provides the host protection from the harmful effects of proteases 
in the extracellular matrix.  However, it has been observed that CPs secreted from T. 
vaginalis have been able to actually degrade CPIs created by the host and thus limit the 
host’s ability to protect itself against infection (Sommer 2005).  This is why there is a 
great need not only for naturally occurring CPIs but also drugs that can be used to inhibit 
protease activities.  An irreversible cysteine protease inhibitor, E-64, is an example of a 





introduced to vaginal epithelial cells (no parasite induced apoptosis was seen in the host 
cells from this interaction).  However, E-64 inhibiting CPs 2, 3, and 4 did not inhibit the 
growth of the parasite in vitro in the absence of host cells (Irvine, 1997). 
 The mechanism of how CPIs work is important to understand when developing 
drugs or looking for other CPIs to inhibit the cysteine protease being studied.  The 
cystatin family of CPIs is a relatively good example of how this mechanism works.  In 
Figure 3, there is a three-dimensional structure of a cystatin cysteine protease inhibitor.  
The length of these proteins is usually around 115 amino acids and these proteins are 
characterized by four key cysteine residues that are able to form 2 disulfide bonds.  These 
features are important to the success of the protein in being able to inhibit the cysteine 
protease. 
 When considering the homology between cysteine proteases of different 
organisms, CPIs can be highly conserved as their function is to inhibit highly conserved 
cysteine proteases.  During an investigation of the genome of T. vaginalis, phytocystatin-
like peptidase (protease) inhibitors were found. Phytocystatin protease inhibitors are 
generally found in plants, inhibiting legumains (Martinez, 2007).  However, there is very 
similar homology between the inhibitor proteins found in T. vaginalis as the one that is 
found in plants.  A BLAST analysis of the sequence of the three T. vaginalis cystatins 
showed that a large majority of the proteins are in fact similar to cysteine protease 
inhibitors, thus leading to a possible conclusion that the they would function like other 
cystatins that have been studied. 
Phytocystatins are cysteine protease inhibitors that are derived from plant sources.  





with a QXVXG binding motif roughly found in the middle of the protein, followed by a 
tryptophan residue near the C-terminus (Shyu, 2011).  As stated previously, they possess 
the ability to inhibit legumain proteins found in plants.  However, they also can be used 
by the plant as a means for self-defense against pathogens such as fungi (Valdes-
Rodriguez, 2010).  When recombinant phytocystatin CPI was introduced to various 
pathogenic fungi growth was severely inhibited.  Although fungi usually provide nitrogen 
nutrients to plants, not all fungi is symbiotic with plants and thus amaranth plants have 
adapted to these types of fungi by use of these phytocystatins.   
 The phytocystatin-like protease inhibitors found in T. vaginalis may be able to 
shed light on the evolutionary past of the parasite, as well as new understanding for 
biochemical processes that take place between the phytocystatin-like protease inhibitor 
and the protease.  These proteins have not yet been studied and it may hold clues to 
enhancing our understanding of how to better inhibit CPs that are released by T. 
vaginalis.  Two hypotheses for the function of these inhibitors are raised by the two roles 
that CPIs have.  One is that these inhibitors reduce the function of T. vaginalis CPs.  The 
other hypothesis is that these inhibitors may target host proteases or they might target 











Chapter 2: Material and Methods 
PCR of Phytocystatin-like Cysteine Protease Inhibitors 
Polymerase Chain Reaction was used to amplify the genes of the CPIs from T. 
vaginalis.  10 µL of water was added to PCR tubes followed by 5 µL of template DNA 
from T. vaginalis.  Next, 2 µL of High Fidelity Taq polymerase buffer followed by 1 µL 
of each primer (at a concentration of 10 µM each) were added.  Lastly, 1 µL of 10 mM 
DNTPs were added along with .25 µL of 5 Prime’s HotMaster Taq polymerase.  The 
thermal cycler was then set to run at 94
o
C for 5 minutes then cycle between 94
o
C for 30 
seconds, 54
o
C for 30 seconds, and 72
o
C for 30 seconds.  After the 35 cycles the samples 
were kept at 72
o
C for an additional 7 minutes and then stored at 4
o
C. 
To check PCR samples, gel electrophoresis was used. 5 µL of the samples were 
mixed with 1 µL of 6x loading dye and then loaded into 1% agarose gel (.35g of agarose 
into 35 ml of TBE buffer and 3.5 µL of 10mg/ ml EtBr) and ran at 150 volts for 35 
minutes. 
Molecular Cloning of Phytocystatin-like Cysteine Protease Inhibitor Genes 
The PCR samples were then ligated into TOPO TA (Tvag.034880 and 
Tvag.272260) and pSC-A (Tvag.127040).  1 µL of salt water solution containing 1.2 M 
NaCl and 0.06 M MgCl2 was added to 4 µL of the PCR samples.  Finally 1 µL of the 
TOPO TA or pSC-A vector was added and the sample was incubated at room 
temperature for 10 minutes.  3 µL of the ligated sample were then added to 25 µL of 





they were placed into a water bath of 42
o
C for 30 seconds.  The sample was placed back 
on ice for 1 minute.  125 µL of SOC media was then added to the cells and the samples 
were incubated in a shaking incubator at 37
o
C for one hour.  After one hour the cells were 
plated on ampicillin agar plates and allowed to grow for 24 hours. 
After 24 hours 7 colonies were taken and placed into 4 ml of LB media containing 
4 µL of ampicillin in culture tubes and grown for 24 hours in a shaking incubator at 37
o
C.  
After 24 hours 100 µL samples were taken from each tube and PCR was conducted to 
ensure the samples contained the gene of interest using the same procedures as before 
with the cell pellet in place of the DNA template.   
The plasmids within the cells were then extracted using Qiagen Spin Miniprep kit.  
The cultures containing the gene of interest were then centrifuged at 16,873g for 2 
minutes in Eppendorf tubes. The cell pellets then took place.  The pellets were then 
resuspended in 250 µL of Buffer P1.  250 µL of Buffer P2 was then added and the tube 
was inverted 6 times.  350 µL of Buffer N3 and mixed by inverting the tubes 6 times.  
The samples where then centrifuged at 16,873 for 10 minutes.  The supernatant was then 
extracted and placed into a spin column and then centrifuged at 16,873g for one minute.  
The flow through was discarded and 750 µL of Buffer PE containing ethanol was added 
to the columns.  The samples were then centrifuged at 16,873g for 1 minute.  The flow 
through was discarded and then centrifuged again for 1 minute.  The column was then 
placed into a 1.5 ml Eppendorf tube and 40 µL of elution buffer was added and let stand 
for 1 minute.  This was then centrifuged for 1 minute at 16,873g. 
The mini prep samples along with the expression vectors then underwent their 





ACC651 and BamHI along with buffer 3 from New England Bio Labs were used, for 
pET-28a BamHI and SalI with buffer 3 were used (Tvag.034880 and Tvag.272260) , and 
for pET-21b (Tvag.127040) XhoI and NdeI along with Buffer 4 were used.  For the 
digests 11 µL of water was added to an Eppendorf tube.  Next, 2 µL of buffer was added 
followed by 2 µL of 10X BSA and 3 µL of the miniprep DNA.  Finally 1 µL of each 
enzyme was added and the sample was placed into a heat block set at 37
o
C overnight.  
The following day samples where then ran out on an agarose gel via gel 
electrophoresis and then the cut fragments were purified using Qiagen gel extraction kit.  
In order to achieve this, the gel pieces were placed into a 1.5 ml Eppendorf tube followed 
by 3 times the amount of the volume of the gel in QG buffer (100mg of gel would result 
in 300 µL of QG buffer).  The sample was then heated to 50
o
C for 10 minutes and 
vortexed occasionally until all the gel had been dissolved.  After heat treatment 1 volume 
of 100% isopropanol to 1 volume of gel was added and mixed. The sample was then 
placed into a QIAquick spin column in a 2 ml collection tube and centrifuged at 16,873xg 
for 1 minute.  The flow through was discarded and 750 µL of Buffer PE with ethanol was 
added to the spin column.  The sample was then centrifuged again for 1 minute at the 
same speed.  The flow through was discarded and again centrifuged for one minute to 
remove any remaining Buffer PE.  The column was then placed into a 1.5 ml Eppendorf 
tube and 30 µl of elution buffer was added.  After 4 minutes, the sample was centrifuged 
at 16,873xg for 1 minute.  The cut and purified inserts and plasmids were then ligated 
together.   
 Ligation of the cut plasmids and inserts were achieved by T4 DNA Ligase.  7 µL 





purified insert, 1 µL of T4 Ligase buffer and finally .5 µL of T4 DNA Ligase was added.  
The samples were then placed into a thermal cycler set at 14
o
C and stayed their 
overnight.  The next day 3 µL of each sample was then used to transform competent 
Top10 E. coli cells using the same method as before. 
Maxiprep for Transfection 
 To maxiprep the plasmids with the inserts for transfection, 500 ml of transformed 
E. coli cells were grown in LB media.  The cells were centrifuged at 5000xg for 10 
minutes at room temperature.  The supernatant was removed and the cells were 
resuspended in 15 ml of Cell Resuspension Solution from Wizard Plus Maxipreps DNA 
Purification System from Promega.  Next 15 ml of Cell Lysis Solution was added and 
then inverted to mix.  After mixing 15 ml of Neutralization solution and inverted to mix.  
The solution was then transferred to two 25 ml centrifuge tubes, balanced, and then 
centrifuged at 14,000g for 15 minutes. 
 After centrifugation the supernatant was filtered through a coffee filter to remove 
any cellular debris into a graduated cylinder.  The volume was then raised by 50% with 
100% isopropanol and inverted to mix.  This new mixture was then centrifuged in 25 ml 
centrifuge tubes at 14,000xg for 15 minutes.  The supernatant was removed and the pellet 
was resuspended with 2 ml of TE buffer. 
 Next, 10 ml of Resin solution was added to the DNA and swirled to mix.  A 
Promega Maxicolumn was attached to a vacuum manifold and the DNA/Resin mixture 
was added to the Maxicolumn.  The vacuum was applied until all liquid had been drawn 
through the filter. Next, 25 ml of Column Wash Solution containing ethanol was added to 





of 80% ethanol was then added to the Maxicolumn and the vacuum was applied and 
continued for 1 minute after all the liquid had been drawn through.  The Maxi column 
was then placed into a 50 ml Falcon tube and was centrifuged in a swinging bucket rotor 
at 1,300xg for 5 minutes.  After this process the Maxicolumn was then attached to the 
vacuum manifold and the vacuum was applied for 5 minutes. 
 The Maxicolumn was then placed into a Reservoir tube provided by Promega.  
1.5 ml preheated (70
o
C) water was then added to the Maxicolumn.  After 1 minute the 
Maxicolumn in the Reservoir tube was centrifuged at 1,300xg for 5 minutes using a 
swinging bucket rotor.  The supernatant containing the DNA was then filtered through a 
.2 µM filter attached to a 5 ml syringe and into a 1.5 ml Eppendorf tube.  The filtrate was 
then centrifuged at 14,000xg for one minute.  The supernatant was then transferred to a 
new 1.5 ml Eppendorf tube. 
 After maxiprep, the DNA concentration of each sample was then quantified with 
a spectrophotometer.  The absorbance was at 260 nm and the concentration was 
calculated by using 1 OD = 50 µg/ml. 
Transfection into G3 and MSA1132 Strain of Trichomonas vaginalis 
 In order to achieve transfection of T. vaginalis, 500 ml of G3 strain cultured 
Diamond’s TYM media was split into 3 250 ml centrifuge bottles, balanced and then 
spun at 1400xg for 25 minutes at 4
o
C.  After centrifugation, the supernatant was removed 
except for 30 ml which was used to resuspend the pellets for all three bottles.  The 30 ml 
was then placed into a 50 ml Falcon tube and again spun at 1400xg for 25 minutes at 4
o
C.  
The supernatant was then completely removed.  100 µg of plasmid with insert was placed 





of the maxiprep DNA while creating little to no bubbles.  The cuvette was then placed 
into a Bio-Rad Gene Pulser II.  The voltage was set to .350 kV and the max capacitance 
was set to 975 µF.    After electroporation for 30 seconds the cells were resuspended 
gently with TYM media and placed into 50 ml of the TYM media in a Falcon tube and 
incubated at 37
o
C.   
 After 24 of growth the cultures were transferred to a new 50 ml Falcon tube and 
centrifuged at 1400xg for 25 minutes.  The supernatant was removed and 50 ml of TYM 
media was added and the pellet was resuspended.  50 µL of 100mg/ ml of compound 
G418 was then added to the tube.  After spending 5-7 days in a 37
o
C incubator, 
transfected cells would show signs of growth. 
Expression of Phytocystatin-like Cysteine Protease Inhibitor Proteins 
 Expression of CPIs in the tetracycline inducible vector was achieved by growing 
the transfected cells in 10 ml of TYM media and for 24 hours.  8 µL of 6.25mg/ ml 
tetracycline was then added to the culture and incubated at 37
o
C for 4 hours.  The cells 
were then pelleted for western blot analysis. 
 For expression in pET-28a and pQE80-L competent BL21 E. coli cells were 
transformed using the same previous methods, however after the recovery step the cells 
were not plated and instead added to 10 ml of LB media containing kanamycin for pET-
28a or ampicillin for pQE80-L and placed in a 37
o
C shaking incubator overnight.  Next 2 
ml of the culture was added to 8 ml of media containing kanamycin or ampicillin as well 
as 10 µl of 1M IPTG for expression of the protein.  These samples were then incubated at 
37
o






analysis.  For large scale induction, the cells were grown in 1.25 l of LB media and 1.25 
ml of 1M IPTG at 37
o
C for 4 hours.   
Western Blot Analysis 
 Samples from protein expression were combined with 2x laemmli sample buffer 
with DTT.  Next the reactions were heated to 95
o
C for 5 minutes.  The samples were 
vortexed occasionally.  Next 30 µl of the samples were loaded into a precast 10 well Bio-
Rad Mini-PROTEAN gel.  The gel was run at 250 volts for 17 minutes using 1X Bio-Rad 
Tris-glycine SDS running buffer.  After electrophoresis, the gel was removed from the 
cast and was readied to transfer the protein to nitrocellulose paper.   
 To transfer the proteins, nitrocellulose paper was placed on top of the gel and 
sandwiched between two thick blot papers, then two foam pads and then clamped 
together by the mini gel holder cassette.  They were then placed into the mini trans-blot 
central core inside the transfer apparatus.  Next an ice pack was placed next to the central 
core and then the apparatus was filled with 1X Tris-glycine Methanol Transfer buffer.  
The transfer was run at 100 volts for 1 hour.   
 After one hour the nitrocellulose blot was removed and 50 ml of 5% milk 
phosphate buffer saline tween (PBST) was added and then placed on a rotator for 20 
minutes at room temperature.  Next the blot was removed and placed into 5 ml 1% milk 
PBST solution along with 5 µl of 1:1000 or 1µl of 1:5000 of primary antibody in a 50 ml 
Falcon tube.  The blot was then placed on a rotisserie and rotated for one hour at room 
temperature.  Next the blot was removed and washed three times with PBST for 5 
minutes each time.  After the third time, the blot was placed into another 50 ml Falcon 





antibody.  This was placed on the rotisserie again for one hour at room temperature.  Next 
the blot was washed again with PBST 3 times for 5 minutes each time.  After the final 
wash 1 ml of horseradish peroxidase (HRP) was added directly onto the protein side of 
the blot.  After two minutes of incubation at room temperature the blot was visualized 
using a Bio-Rad ChemiDoc XRS. 
Protein Purification 
 To purify the expressed protein from the large scale induction, the protocol from 
QIAexpressionist by Qiagen was used.  The cells were pelleted at 5000g for 10 minutes 
at room temperature.  The pellet was then resuspended in Buffer B (13.8 g NaH2PO4, 1.2 
g Tris base, 480.5 g urea and brought up to 1 l with Millipore water and adjusted pH to 
8.0 using NaOH) by swirling gently for one hour.  Every 15 minutes the cells were lysed 
using sonication.  Once the cells were lysed, the solution was centrifuged at 10,000g for 
25 minutes at room temperature.  The supernatant was then poured into a filter column.  
Then 1 ml of Ni-NTA slurry was added to the lysate supernatant.  The mixture was then 
placed on a rotary shaker at 200 rpm for one hour.  After one hour the cap from the 
bottom of the column was removed and the bottom and the flow through was collected 
for western blot analysis.  The column was then washed with 21 ml of Buffer C (same 
chemical make up as Buffer B but the pH is adjusted to 6.3 with HCl).  The washes were 
then collected for western blot analysis.  Finally the column was eluted with 21 ml of 
buffer D (same chemical make up as Buffer B but the pH is adjusted to 5.9 with HCl) and 







Dialysis of Cystatins 
10 mL of purified cystatin was pipetted into a 15mL dialysis cassette.  Using a 
beaker, the cassette was placed into 1 L of 20 mM Tris, 150 mM NaCl at pH 6.2 (TBS).  
The beaker was then placed on a stir plate in a cold room for 2 hours.  After 2 hours, the 
TBS was poured out and replaced with another liter of TBS for 24 hours.  The dialyzed 
purified protein solution was then collected, centrifuged at 13,000g for 10 minutes to 
remove insoluble fraction, aliquoted into 10 1.5 ml Eppendorf tubes, and place in a -20 
freezer for storage. 
Peirce BCA 
 To quantify the amount of protein purified, Pierce BCA kit was used. 100 µl of 
known concentrations of BSA and unknown concentrations of purified cystatin were 
added to 2ml of working reagent in test tubes.  The tubes were then placed into a 37
o
C 
water bath for 30 minutes.  After this time the solution in the tubes were transferred to 
cuvettes to be read in a spectrophotometer.  The absorbance was detected at a wavelength 
of 562nm for each cuvette.  The absorbance was then graphed against the known 
concentrations of BSA to create a linear regression line that could be used to predict the 
unknown concentrations of the Cystatins.   
Papain Inhibition Assay 
First papain (a cysteine protease) from papaya was diluted from a stock 
concentration of 10 mg/ml to a 100 µg/ml concentration in a 50 mM Tris, 5 mM DTT 
solution.  After incubating on ice for 15 minutes, the solution was then diluted 1:50 in a 
50 mM Tris, 5 µM BSA.  25 µl of the papain solution and 25 µl of each cystatin 







C in a water bath for 15 minutes.  Heat treated cystatin was incubated at 100
o
C for 15 
minutes before being placed into an ice bucket and then had the papain solution added. 
 After 15 minutes in the water bath, the cystatin/papain solutions were then diluted 1:5 
with 50mM Tris.  From each tube 3 50 µl samples were placed into three wells of a 96 
black well plate allowing for the experiment to be run in triplicate. The fluorescent 
substrate Z-FR-AMC was diluted from a 158 mM stock to 200 µM in 50 mM Tris, 2.5 
mM DTT.  Once the plate reader was prepped for this experiment, 50 µl of the 
fluorescent substrate was added to each well and the experiment was started.  The plate 
reader would then read the plate every minute and the data was exported to an excel 
sheet. The data could then be turned into graphs and was also exported to Graphpad 
Prism where further interpretation could be done. 
Zymogram Gel Electrophoresis 
 10
7 
of T. vaginalis cells were resuspended in 1 mL of a lysis buffer containing 
10% glycerol, .6% Triton X-100, 100mM Tris-HCl pH 6.8, and 150 mM NaCl.  The 
lysed cells were then kept on ice.  50µl of Zymogram sample buffer (4.4ml DDH2O, 1ml 
.5M Tris-HCl pH6.8, .8 ml glycerol, 1.6 ml 10%SDS, .2ml .5% bromophenol blue) was 
added to 150µl of the lysed cells.  The zymogram gels were created by using a 10 well 
10% polyacrylamide SDS gel containing 1% gelatin. 20 µL of the cell lysis was then 
added to every other lane and a protein marker was loaded into the unused lanes.  The gel 
was run at 35 mA for about 30 minutes or until the sample dye ran off the gel.  The gel 
was removed from the cast and washed using roughly 20 mL or more of a Wash Buffer 
(.1M Sodium Acetate pH 5.5, 2.5% Triton X-100) at 4
o
C for 30 minutes.  The Wash 





poured out and the gel was placed into a .1M Sodium Acetate pH 5.5 solution at room 
temperature for 5 minutes.  The gel was then cut into 5 pieces containing 1 protein 
marker and one lane consisting of 1.6x10
5
 cells of T. vaginalis protein. The cut strips 
were then placed into 15 ml conical tubes consisting of dialysis buffer with BSA and 
1mM DTT along with one of the following or none, 10µM E64, 10µM cystatin, 1µM 
cystatin, and .1µM cystatin.  The 5 tubes were then placed on a rotator machine for 2 
hours at 37
o
C.  After the two hours the solutions were poured out and Coomassie Brilliant 
Blue was poured into the tubes.  After an hour on the rotator, the gels were destained 
overnight using 5% methanol and 10% acetic acid.  
Immunofluorescence Co-localization 
 For co-localization of the Cystatins with known cysteine protease Legumain 1, 3 
ml of each transfected culture and wild type culture were centrifuged at 3200 rpm for 5 
minutes.  The supernatant was removed and the pellets were resuspended in 1 ml of PBS-
sucrose and placed into 1.5 ml Eppendorf tubes.  The tubes were centrifuged at 4000 rpm 
for 5 minutes and the supernatant was removed.  The pellet was then resuspended in 200 
µl of PBS-sucrose and 500 µl of methanol was added.  This was incubated on ice for 10 
minutes.  After ten minutes the tubes were centrifuged at the previous settings again.  The 
pellets were resuspended in 500 µl of PBS-sucrose and again centrifuged at the previous 
settings.  This time the cells were resuspended in 500 µl 3% BSA PBS for 30 minutes at 
room temperature on a rotating plate.  The tubes were then centrifuged again at 4000 rpm 
for 5 minutes.  After centrifugation the supernatant was removed and the pellets were 
resuspended in 500 µl 3% BSA PBS and two primary antibodies, anti-HA at 1:1000 





temperature on a rotating plate.  After one hour the tubes were centrifuged at 4000 rpm 
for 5 minutes.  The pellets were resuspended in 500 µl of PBS and centrifuged again at 
the same settings.  This repeated a second time to wash the pellets of unattached primary 
antibody.  After the second centrifugation the cells were resuspended in 3% BSA PBS 
containing secondary antibodies, anti-mouse green and anti-rabbit red at 1:5000 dilutions.  
The tubes were then foil wrapped and incubated for 1 hour at room temperature.  After 
one hour the tubes were centrifuged at 4000 rpm for 5 minutes and resuspended in 500 µl 
of PBS.  The tubes were centrifuged again at the same settings and resuspended in PBS.  
2 µl from each tube were then placed into 2 µl drops of DAPI on 4 different microscope 
slides.  The DAPI-cell solutions were then covered by a coverslip and placed in a 37
o
C 
incubator for 1 hour and then placed into a -20 freezer overnight.  The slides were 
visualized by a fluorescent microscope and using the program AxioVision.  
RNA Extraction 
Invitrogen’s TRIzol was used to extract mRNA from T. vaginalis cells to detect 
expression of CPIs.  First 10 ml of cultured G3 strain of T. vaginalis were centrifuged at 
1200g for 25 minutes.  Next the media was removed and the pellet was resuspended in 1 
ml of TRIzol reagent was added and mixed.  After incubating at room temperature for 5 
minutes, 0.2 ml of chloroform was added.  The sample was shaken vigorously for 15 
seconds and incubated at room temperature for 3 minutes.  The sample was then 
centrifuged at 12,000g for 15 minutes at 4
o
C.  The upper aqueous layer was then removed 
and placed into a 1.5 ml Eppendorf tube.  Once in the new tube, 0.5 ml of 100% 
isopropanol was added.  The sample was incubated at room temperature for 10 minutes.  
The sample was then centrifuged at 12,000g for 10 minutes at 4
o





removed and the pellet was washed with 1 ml of 75% ethanol.  The sample was briefly 
vortexed and then centrifuged at 7500g for 5 minutes at 4
o
C.  The supernatant was then 
discarded and the pellet was air dried for 10 minutes.  The pellet was then resuspended in 




After extraction, the RNA concentration of each sample was then quantified with 
a spectrophotometer.  The absorbance was at 260 nm and the concentration was 
calculated by using 1 OD = 40 µg/ml.  1 µg of RNA was added to 1 µl of 10x DNase 
reaction buffer and the volume was brought up to 9 µl with RNase free water.  Then 1 µl 
of DNase 1 (ampicillin grade) was added and the sample was incubated at room 
temperature for 20 minutes.  1 µl of 25 mM EDTA was added and heated to 65
o
C for ten 
minutes.  After 10 minutes, 1 µl of oligo DT (diluted 1:5) and 1 µl of 10 mM RNA work 
dNTPs were added to the reaction.  The reaction was then again incubated at 65
o
C for 5 
minutes.  The reaction was placed on ice for one minute after incubation.  The reaction 
was then centrifuged for one minute at 16,873g.  4 µl of 5x first strand buffer, 1 µl of 0.1 
M DTT, 1 µl of RNase out where then added to the reaction.  1 µl of Superscript was 
then added to the reaction and 1µl of DEPC water was added to the negative control.  The 
reaction was mixed by flicking and was then incubated for one hour at 50
o
C to allow the 
reaction to occur.  After the hour, the reaction temperature was raised to 70
o
C for fifteen 
minutes to inactivate the reaction.   
The cDNA sample could now be used as template DNA for PCR and these were 







Co-culture of HeLa and the MSA1132 strain of T. vaginalis where conducted in 
the presence of recombinant cystatins.  On a 96 well plate, HeLa cells were allowed to 
grow on the bottom of the wells overnight in 200 µl DMEM media to roughly 70-90% 
confluency.  The next day the DMEM was removed and 100 µl of fresh DMEM was 
added.  MSA1132 T. vaginalis was also grown overnight until confluent.  25 µl of this 
culture was added to 25 µl of the testing concentration of recombinant cystatin 
(containing 10 µm BSA), E64, or negative control (dialysis buffer with BSA), and 50 µl 
of DMEM.  This was incubated for two hours before being added to the HeLa cultures in 
the 96 well plate.  This co-culture was then incubated for 3 to 12 hours before taking 
images and staining. 
Co-culture Staining and Absorbance Readings 
The MSA1132 and HeLa Co-cultures were stained using crystal violet.  First the 
wells were washed twice with 100 µl of PBS.  Then one drop of crystal violet was added 
to each well incubated at room temperature for 10 minutes.  Next the wells were washed 
twice with 100 µl of PBS.  Absorbance readings at 590nm wavelength were taken of each 
well.  Next, 100 µl of 1% SDS were added to each well and mixed.  Absorbance readings 










Chapter 3: Results 
Clustal Alignment 
To compare the different CPIs a Clustal alignment was done and can be seen in 
Figure 4.  In this figure we see the QXVXG motif of cystatins and NPTTG motif of 
chagasin boxed in green.  There are some mutations in this region that distinguishes one 
cystatin from the others, specifically, Tvag.272260 has a Lysine amino acid instead of a 
Glutamine amino acid to start the motif off. Tvag.034880 has an Isoleucine instead of a 
Valine like the other two at the second position of the motif. All three end the motif with 
a Valine, Serine, and Glutamine. This mutation may affect how the cystatin behaves 
against cysteine proteases, possibly lowering its efficiency or having a narrowed range of 




Figure 4. Clustal alignment of cystatins and chagasins. The green box region represents 





Recombinant Expression of Cystatins in T. vaginalis Cell Line 
The three cysteine protease inhibitors were cloned a tetracycline inducible Master 
Neo vector.  The Master Neo added an HAHA tag to the C terminus of the protein. 
Figure 5 shows Tvag.272260 induced for a period of 4 hours with a sample taken at each 
hour.  The best expression occurs between 2 and 3 hours into the induction.  The 
uninduced negative control (labeled O UNI) did, however, show that the inhibitor is 
expressed even in the absence of tetracycline.  The difference in amount of protein being 
expressed is due to culture density as the uninduced sample was taken from a much 
denser culture than the expressed culture.   
Tvag.034880 and Tvag.127040 were also cloned into the tetracycline inducible 
Master Neo vector.  Figure 6 shows the uninduced expression of all three cystatins while 
in transfected T. vaginalis MSA1132.  Again we see that the protein is expressed even in 
the absence of tetracycline.  Expression from Tvag.034880 was not detectable by western 
blot analysis.  
The transfected G3 with Tvag.127040 was shown to have the same morphology 
as non-transfected G3.  The overexpressing line with Tvag.272260 does not display 
normal morphology, as seen in Figure 9 versus Figure 8.  In Figure 7 we see G3 which 
normally has a round shape and can have an elliptical shape when displaying mobility.  In 
Figure 9 we see that the cells maintain an elongated shape and do not display a normally 
circular shape.  The effect of the inhibitor does not appear to inhibit the growth of the 
parasite in medium.  Figure 8 is used as a control to show that an empty vector does not 







Figure 5.  Western Blot of induced expression of Tvag.272260 in transfected T. 
vaginalis. The expression for the cystatin is labeled O along with the time of the 
induction in hours.  The positive control was also induced for protein expression and is 






Figure 6. Western blot showing expression of Tvag.034880, Tvag.127040, and 
Tvag.272260 in transfected T. vaginalis. The amount of protein loaded was normalized 
















Figure 9. G3 strain of Trichomonas vaginalis overexpressing Tvag.272260. 
 
Recombinant Expression in BL21 E. coli 
 Originally, Tvag.034880 was cloned into pQE80L plasmid that resulted in a 
single N terminus his-6-tag.  After months of trying to express the protein in this plasmid 
recombinant expression was not achieved.  The bacteria did not express it well enough to 
purify identify the target cystatin or the tag was possibly removed by post translational 
signaling.  I then looked into pET28-a which not only had an N terminal his-6-tag but 





plasmid I decided that using a vector with an N and a C terminal tag might be able to 
allow it to become detectable by western blot analysis.  Using pET-28a and pET-21b, I 
was able to clone all three cystatins and recombinantly express them.  Figures 10 and 12 
show a Coomassie Blue stain of a 17.5% polyacrylamide gel with the purification of 
Tvag.034880, Tvag.272260 and Tvag.127040 and appear to have ample protein available 
for experimentation.  Figures 11 and 13 confirm 6his tagged expressed cystatins by 
western blot analysis.  Multiple bands at larger weights might be seen in eluted region 
which could be due to dimers and trimers that may have formed. Bands that are lower 






                                    M     FT    W1   W2     E1    E2    M     FT     W1    W2   E1   E2 
Figure 10. Coomassie blue stain of Tvag.034880 and Tvag.272260 purifications. 
Purifications are from large scale induction in BL21 E. coli.  M stands for protein marker, 
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Papain inhibition assays 
Figures 14, 15, and 16 show the raw data from the papain inhibition assay over 
the course of 30 minutes.  Figure 17 compiles the first 15 minutes of data to establish a 
rate of change of activity.  The increasing activity with lowering the concentration of 
cystatin suggest that there is a dose dependency relationship between the cystatins and 
cysteine proteases.  It’s interesting to note that heat did not have an effect on 
Tvag.127040 and Tvag.272260; however, it did affect Tvag.034880.  This may suggest 
that structure of Tvag.034880 is more important for its function than the other two 
cystatins. 
Based on Figure 18 we can see that the inhibitor with the greatest effect on the 
papain enzyme was Tvag.034880 as its IC50 value was .097 µM. Tvag.127040 had the 
next greatest effect on the papain with an IC50 of .142 µM followed by Tvag.272260 











Figure 14.  Graph of Tvag.034880 vs. papain. Purified and dialyzed cystatin incubated 
with known cysteine protease papain. Note that HT stands for Heat Treated cystatin. The 
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Figure 17. Graph comparing rates of reaction for the three cystatins vs. papain. The rates 



















Figure 18. Graph depicting IC50 values for each cystatin vs. papain. IC50 values 





























































Figures 19, 20, and 21 demonstrate that the cystatins have an effect on T. 
vaginalis endogenous proteases.  In all three figures the inhibition of the proteases was 
dose dependent as less cystatin concentration increased the protease activity.  
Tvag.034880 appeared to have less of an effect than the other two cystatins.  However, 
the control for Tvag.127040 seemed to have less activity.  Without quantitative analysis it 
would be difficult to determine which cystatin was most effective and so the only 
conclusion is only that cystatins had some effect on the endogenous proteases. 
It also appears that the smaller size proteases were affected more by the cystatins 
than those at a higher weight.  This would be expected as the lower weight bands 
















        







CPI Localization in Transfected Strains and Co-localization with Legumain 
In Figure 22, it appears that cystatin C is in vesicles due to the punctate red dots.  
The reason why Tvag.034880 was detected by using an immune-fluorescent assay is due 
to the greater sensitivity of this assay versus a western blot analysis.  Cystatins M and O 
appear in both the cytoplasm throughout the cell and in punctate vesicles as well.  The 
tetracycline inducible system does appear to also produce more cystatins when induced 
than when uninduced.  Not all cells appeared to be producing cystatins. However, the 
level of florescence was normalized against the background found in the negative control 
(MSA1132 only) and those with higher levels of red are depicted. 
In Figure 23, the cystatins were co-localized with legumain.  The punctate yellow 
vesicles appear to show that all three cystatins co-localize with legumain in what could be 





Figure 22. IFA of localization of cystatins.  Nuclei stained with dapi in blue and anti-
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RT-PCR of Different T. vaginalis Strains 
In table 1, the primers used for PCR and RT-PCR reactions are listed.  As seen in 
Figures 24 and 25 there appears to be no expression for Tvag.034880 in both B7RC2 and 
B7268 strains of T. vaginalis as the positive control for TvMIF was seen and the negative 
control did not amplify.  However in Figures 27, 28, and 29 we see that the negative 
controls amplified (except for TvMIF) and thus no conclusions can be drawn about the 
possibility of the CPIs being expressed endogenously. To find out why the negative 
controls amplified I ran a PCR reaction without any template DNA to see if there was 
contamination in any of the reaction buffers.  In Figure 29, it doesn’t seem that DNA 






 Next I wanted to check the RNA extraction to see if there was a large amount of 
genomic DNA in the samples from the three different strains of T. vaginalis. This can be 
seen in Figure 30 and it does not appear to show any large amounts of genomic DNA 
from which the CPIs genes are amplified from.  The only lane with possible DNA is from 
the B7268 strain which did not yield a false positive in Figure 25 but did result in false 




Table 1. List of primers used for RT-PCR.  
 
Tvag.034880 F TTCCTCATGGTTGATGAGACAG 
Tvag.034880 R ATAGATTCCGCCTGATGTTTTG 
Tvag.034880 Mid F CATTCAAAGATCTGAATGATAA 
Tvag.034880 Mid R CCAATACTTTAACAAACTTGAT 
Tvag.034880 End R CTTCGATTTCGAATTCATTA 
Tvag.127040 F CCAGCTAATGTTGATGACGAAC 
Tvag.127040 R TTCCTTCTCTGTGTTTCCTGGT 
Tvag.272260 F CAGGATGAACATGTTATCCAGG 
Tvag.272260 R CTTCTCGAAGAGCTGAAGTTCC 







Figure 24. RT-PCR of the B7RC2 strain of T. vaginalis. Two different primer sets for 





Figure 25. RT-PCR of the B7268 strain of T. vaginalis. Two different primer sets for 






Figure 26. RT-PCR of the B7RC2 strain of T. vaginalis with all cystatins.  






Figure 27. RT-PCR of the B7268 strain of T. vaginalis with all cystatins. All three CPIs 






Figure 28. RT-PCR of the MSA1132 strain of T. vaginalis.  All three CPIs were tested 













Figure 30.  Gel electrophoresis of extracted RNA from the MSA1132, B7RC2, and 




Co-culture of MSA1132 with HeLa in the Presence of Recombinant Cystatins 
In Figure 31, a co-culture HeLa and MSA1132 display the ability of MSA1132 to 
decimate the HeLa cells in three hours.  Based on using BSA and E64 as controls, it 
appears that the cystatin-like protease inhibitors slow down the parasites cytotoxicity on 
host cells in in vitro as more HeLa cells seem to be intact in the visualization. In an 
attempt to quantify the visualizations, a plate reader was used to analyze the absorbance 
of crystal violet added to the 96 well plates, which stains live cells.  This data can be seen 
in Figures 32 and 33.  
In Figure 33 a general observation shows that the cystatins may have decreased 
the cytotoxicity of the parasite against the host HeLa cells due to higher average 
absorbance levels. The mean values for Tvag.034880, Tvag.127040, Tvag.272260, and 
E64 at 10µM are 2.54, 2.97, 2.46, and 2.56 respectively.  The mean values for 





respectively.  The mean values for Tvag.034880, Tvag.127040, Tvag.272260, and E64 at 
5µM are 2.55, 3.07, 2.97, and 2.89 respectively.  The BSA and no parasite controls had a 
mean of 2.30 and 2.76 respectively.  A statistical significance can be found in C5 and M1 
with p-values of 0.034, and 0.049 respectively.  This would go against the idea that 
higher concentrations of cystatins would be more likely to protect the host cells from the 
cytotoxic effects from the parasite.  It could be possible that not only are the host cells 
stained, but so are the parasite cells and this could lead to higher absorbance of crystal 
violet.  This experiment may have needed to be run longer to get accurate results. 
In Figures 34 and 35, the co-culture was allowed to go for 12 hours instead of 3 
hours.  Again we see from the images that there appears to be more cytotoxicity of host 
cells by the MSA1132 in the control wells compared to the test samples, and there is 
statistical significance in the ability of Tvag.272260 to inhibit the parasite against host 
cells with a P value of 0.016.  The mean values for Tvag.034880, Tvag.127040, 
Tvag.272260, E64, and BSA control are 0.43, 0.40, 0.30, 0.26, and 0.14 respectively.  
The lack of statistical significance from the other two cystatins is due to large variations 
of absorbance levels despite having means greater than the control.  If I had solubilized 
the crystal violet before running on the absorbance levels using the plate reader, it could 






Figure 31. 3 hour co-culture of HeLa and MSA1132 visualized with crystal violet. The 








Figure 32. Absorbance at 590nm wavelength of the MSA1132 and HeLa co-cultures 





Figure 33. Absorbance at 590nm wavelength of the MSA1132 and HeLa co-cultures 
after solubilizing the crystal violet. The error bars are based on the standard deviation. 

































































Figure 34. Co-culture of MSA1132 with HeLa cells for 12 hours, visualized with 
crystal violet.  The concentration of the Cystatins, BSA, and E64 are at 10 µM and 
2.66x10
4





Figure 35. Absorbance of crystal violet stained HeLa and T. vaginalis 12 hour co-
culture. 
  Error bars are based on the standard deviation. Asterisk denotes statistical 


















Chapter 4: Discussion 
 Knowing that cysteine proteases play a role in the growth and virulence of 
Trichomonas vaginalis, these three phytocystatin-like protease inhibitors may be the key 
to understanding how these CPs may be regulated in the cell.  We speculate that 
Tvag.127040 may be the best player of the three cystatins as it inhibited papain fairly 
well compared to the other cystatins, and it efficiently inhibited T. vaginalis cysteine 
proteases.  It appeared that although all three cystatins are capable of slowing the attack 
of parasites on HeLa cells, Tvag.127040 was overall the most effective.  It could be 
possible that this was due to less degradation of this particular cystatin compared to the 
other two.  The Coomassie blue and western blot analysis do not show conclusively that 
the purified cystatins are fully intact and it’s possible that there are small fragments that 
were purified that could have had an effect on quantifying the amount of protein present 
thus leading to a perceived lower effectiveness.   
Based on the zymogram gel assays the three cystatins do target multiple cysteine 
proteases and with specificity as the lower concentration of cystatin resulted in more T. 
vaginalis CP activity.  Tvag.034880 has a secretion signal and given that it was efficient 
against papain but had only minimal affinity towards T. vaginalis CPs, its normal targets 
may not be of parasite origin but possibly host CPs such as those found in the immune 
system.  This cystatin is also not as closely related to the other cystatins based on 
sequence data and its efficiency blocking papain was lowered when exposed to heat.  The 





analysis.  To help detect the cystatin it was cloned into pET28-a which gave the peptide 
sequence an N and C terminal his-tag.  This allowed the protein to be detected and 
purified.  
All three cystatins inhibited papain as expected from previous work on testing 
cystatins against papain (Martinez, 2007).  However, Tvag.272260 did not inhibit papain 
as efficiently as the others.  We speculate that this is due to a mutation in the binding 
motif from QXVXG to KVVSG which was conserved in the other two inhibitors.   
The RT-PCR reactions did not yield results that could determine if transcription 
of the cystatins would occur endogenously in the parasite.  A possible reason for this is 
that the PCR aspect of the process was allowed to go for 35 cycles which could have 
resulted in false positives as background DNA not cleaved by DNase and thus the 
reaction would have maxed out. This could be repeated at a varying number of cycles to 
optimize for the cystatins or by using Q-PCR, a technique that was not available at the 
time I was conducting this experiment.  Further analysis could yield a clearer picture of 
the endogenous expression of the cystatins in native wild type T. vaginalis and under 
varying circumstances such as growing in the presence of host cells and not just in 
culture medium. 
 The expression of the protein in the tetracycline inducible Master Neo is not well 
regulated as both Tvag.127040 and Tvag.272260 are both being expressed without 
induction in the G3 strain.  In MSA1132 this expression might be more tightly regulated 
as seen in Figure 22 the induced cultures produced brighter florescence than the 
uninduced cultures.  As previously explained that Tvag.034880 might require an N 





visualized in transfected T. vaginalis. This made it undetectable by western blot analysis; 
however, it was able to produce punctate signals in the IFA experiments just as the other 
cystatins.  Cystatin M and O do appear throughout the cytoplasm of the cells and not just 
in vesicles in Figure 22.  This seems to support previous work done on Tvag.272260.  
Research conducted in 2015 showed that the cystatin was found throughout the 
cytoplasm and had some overlap with lysosomes (Puente-Rivera, 2015).  It is interesting 
to note that Tvag.034880 does not appear to be found throughout the cytoplasm, but 
rather in punctate vesicles.  This could mean that the cystatin serves a different role than 
Tvag.127040 and Tvag.272260. 
One reason why all of the cells were not expressing the cystatin is that the T. 
vaginalis cultures had only been growing for a few days and had just had G418 selection 
added.  I would expect to see more cells expressing the cystatins if the culture had been 
growing for a longer length of time.   
The IFAs do show some co-localization with a known cysteine protease legumain.  
Legumain is a different family of cysteine protease from papain which was used for the 
enzyme activity assays, however, given that the cystatins targeted multiple CPs in the 
zymogram assay it’s possible that they might be able to target legumain.  The IFAs did 
help to back up that theory as we see punctate HA-tagged cystatin and legumain in the 
same vesicles.  These vesicles would be hypothesized to be lysosomes or possibly 
exosomes that the parasite utilizes to attack host cells.  Again this work would support the 
findings from previous research conducted on Tvag.272260 as it was found to somewhat 






Although Figures 32 and 33 do not show statistically significant data to align with 
the visually collected images, there is a reason why this method is not the most accurate 
for quantification.  In the images it appears that there are still MSA1132 cells attached to 
either the plate or the HeLa cells they are attacking.  This would result in the parasite 
cells taking in the crystal violet and thus leading to increased absorbance.  This could be 
the reason why there was not more of a significant difference between the absorbance of 
the wells with the cystatins, and those without.  This would also explain why there 
appears to be an improvement of cystatin inhibition at 1 µM for all three cystatins and 
lack of a dose dependent curve like the papain experiment. 
For Figures 34 and 35 Tvag.272260 was the only cystatin to show statistical 
significance despite having the lowest average absorbance of the cystatins.  This is due to 
the standard deviation of the other cystatins being large due to an uneven absorbance 
reading.  This data might suggest that the cystatins did protect the host cells from 
cytotoxicity from the parasite.  Based on previous work on Tvag.272260, protection of 
the host cells was observed in co-culture experiments (Puente-Rivera, 2014).  My work 
seems to corroborate the previous findings and adds to it with Tvag.034880 and 
Tvag.127040 potentially showing protection as well.   
We also speculate that based on the nature of T. vaginalis and its relatives that 
these cystatin like protease inhibitors could have been utilized by the parasite in the gut to 
block host proteases from attacking the parasite.  This defense mechanism could also be 
used to block the host immune response from degrading the parasite. Further studies 
could test this by showing that the cystatins block gut proteases by either substrate 
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